Abstract
The human T-cell leukemia virus type-1 (HTLV-1) pX-encoded accessory factors, p30II and Hbz, suppress proviral gene expression and help to maintain latency as a prerequisite for the development of adult T-cell leukemia/lymphoma (ATLL). Our laboratory is studying how these viral proteins influence host cellular gene expression and signaling which may contribute to hematological disease progression. There are five clinically-defined stages of HTLV-1-associated disease (pre-ATLL, smoldering T-cell leukemia, chronic T-cell leukemia, acute T-cell leukemia, and non-Hodgkin’s T-cell lymphoma) and the transitional molecular events which lead to acute/lymphoma-stage disease are not well understood. We have previously shown that p30II interacts with the c-MYC oncoprotein and enhances c-MYC-dependent transactivation and oncogenic potential by stabilizing recruitment of the TIP60 acetyltransferase to p30II/c-MYC/TIP60 transcription complexes. We now extend these findings by demonstrating that p30II induces acetylation of the c-MYC protein. Acetylation-defective Lys --> Arg substitution mutants of c-MYC (R5, K323R/K417R) are impaired for oncogenic foci-formation by p30II/c-MYC. Acute/lymphoma-stage ATLL clinical isolates frequently exhibit overexpression of c-MYC, due to 8q24 chromosomal translocations and/or c-myc gene amplification, and the HTLV-1-transformed T-cell-lines HuT-102 and MJG11 display significant acetylation of c-MYC. The p53 tumor suppressor is a downstream target of c-MYC and, coincidentally, most ATLL leukemic lymphocytes contain high intracellular levels of wildtype p53. Our recent studies demonstrate that p30II activates p53 and induces the expression of p53-dependent anti-apoptotic genes which could promote oncogene-activation and contribute to ATLL tumorigenesis. These findings as well as a novel role for p30II in the long-term proliferation of lentiviral-p30II-transduced primary human T-lymphocytes will be discussed.
Highlights
The human T-cell leukemia virus type-1 (HTLV-1) pXencoded accessory factors, p30II and Hbz, suppress proviral gene expression and help to maintain latency as a prerequisite for the development of adult T-cell leukemia/lymphoma (ATLL)
Our laboratory is studying how these viral proteins influence host cellular gene expression and signaling which may contribute to hematological disease progression
We have previously shown that p30II interacts with the c-MYC oncoprotein and enhances c-MYC-dependent transactivation and oncogenic potential by stabilizing recruitment of the TIP60 acetyltransferase to p30II/ c-MYC/TIP60 transcription complexes
Summary
The human T-cell leukemia virus type-1 (HTLV-1) pXencoded accessory factors, p30II and Hbz, suppress proviral gene expression and help to maintain latency as a prerequisite for the development of adult T-cell leukemia/lymphoma (ATLL). Cooperation between the human T-cell leukemia virus type-1 p30(II) protein and host cellular factors during oncogenic transformation and retroviral carcinogenesis Megan Romeo*, Braden Barnett, Janice Kim, Paige Seeker, Jeffrey He, Alexander McRae, Fahmida Musharof, Hayley Heatley, Afrida Faria, Jennifer Tran, Jordan Milam, Robert Harrod From 16th International Conference on Human Retroviruses: HTLV and Related Viruses Montreal, Canada.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.